The core value of CreaSol® lies in its clear positioning as a synergistic partner to creatine, and MolTek Nutrition has built a systematic intellectual property portfolio around this application direction.
CreaSol®-related technologies are supported by multiple patent assets, including [US12,390,425B1], [US 12,564,564B2], and [WO 2026/086649]. Together, these patents and patent applications reflect MolTek Nutrition’s continued IP strategy around the core applications of CreaSol®, while helping establish a clearer technology barrier in areas such as sports performance, creatine synergy, endurance support, fatigue management, and related formulation development.
For brands looking to develop next-generation creatine products, CreaSol® is not simply another functional ingredient to add into a formula. It represents a differentiated solution supported by both scientific evidence and intellectual property protection.
Combined with published human clinical research, practical dosage, clean taste, and a multi-layer patent portfolio, CreaSol® provides brands with a clearer, better-protected, and more differentiated pathway to upgrade creatine-based products.